Macular Disease Foundation Australia has been named NGO of the Year at the 2026 PRIME Awards, recognising the Foundation’s outstanding contribution to healthcare, patient outcomes and support for Australians living with macular disease.
The national recognition comes during a milestone year for the Foundation and reflects its impact helping Australians living with macular disease to maintain their independence, confidence and quality of life. Macular disease is the leading cause of blindness and severe vision loss in Australia, affecting an estimated 1.9 million Australians.
CEO Dr Kathy Chapman said the award was a fitting way to conclude the Foundation’s 25th anniversary year and reflects the collective efforts of the entire macular disease community.
“This recognition belongs to every person who has contributed to our mission over the past 25 years. It demonstrates what can be achieved when people unite behind a cause that changes lives. Together, we have helped more Australians maintain their sight, independence and quality of life, while driving meaningful advances in awareness, advocacy, research, treatment information and support.”
Presented in Sydney on 19 November, the PRIME Awards celebrate excellence across the healthcare sector. The NGO of the Year category recognises not-for-profit organisations that deliver meaningful improvements in healthcare and patient outcomes.
Dr Chapman congratulated the other finalists in the category and acknowledged the important work being undertaken by not-for-profit organisations across the healthcare sector.
“We are honoured to be recognised alongside such a high-calibre group of organisations making a real difference to the lives of Australians. The strength of the finalists highlights the extraordinary contribution of the for-purpose sector in improving health outcomes across the country.”
The Foundation was also a finalist in the Best Public Health Initiative category for its Eye Connect program. Eye Connect is a free support service that helps people living with macular disease between clinical appointments and has demonstrated strong outcomes for participants receiving treatment..
Looking ahead, Dr Chapman said the award would provide additional momentum as the Foundation continues to advocate for earlier detection, improved treatments, research investment and better support for people living with macular disease.
“While this award recognises what has been achieved, it also inspires us to keep pushing forward. There is still important work to do, and we remain committed to ensuring every Australian living with macular disease has access to the care, information and support they need. Our determination is driven by the people and families who place their trust in us every day.”
Please click here to see the fill list of finalists


Finalist for two PRIME Awards
Finalist for two PRIME Awards
Macular Disease Foundation Australia (MDFA) is a finalist in two categories at the 2026 PRIME Awards, which acknowledge excellence in healthcare communications and patient engagement. MDFA is a finalist for NGO of the Year and Best Public Health Initiative for Eye Connect.
